Commonwealth Equity Services, LLC Kala Pharmaceuticals, Inc. Transaction History

Commonwealth Equity Services, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$0.3 - $1.31 $360 - $1,572	-1,200 Reduced 10.53%	10,192 $3,000
Q4 2021 Jan 31, 2022	SELL	$1.16 - $2.74 $1,842 - $4,351	-1,588 Reduced 12.23%	11,392 $13,000
Q3 2021 Oct 29, 2021	SELL	$2.62 - $5.43 $3,513 - $7,281	-1,341 Reduced 9.36%	12,980 $34,000
Q2 2021 Aug 11, 2021	BUY	$5.06 - $8.15 $5,844 - $9,413	1,155 Added 8.77%	14,321 $75,000
Q1 2021 May 04, 2021	SELL	$6.24 - $9.58 $29,172 - $44,786	-4,675 Reduced 26.2%	13,166 $88,000
Q4 2020 Feb 11, 2021	BUY	$6.28 - $8.79 $31,676 - $44,336	5,044 Added 39.42%	17,841 $120,000
Q2 2020 Aug 12, 2020	BUY	$8.33 - $13.79 $11,662 - $19,306	1,400 Added 12.28%	12,797 $134,000
Q4 2019 Feb 05, 2020	BUY	$3.36 - $4.81 $1,626 - $2,328	484 Added 4.44%	11,397 $42,000
Q1 2019 May 13, 2019	BUY	$5.19 - $8.97 $2,470 - $4,269	476 Added 4.56%	10,913 $90,000
Q4 2018 Feb 11, 2019	SELL	$4.29 - $9.94 $13,144 - $30,456	-3,064 Reduced 22.69%	10,437 $51,000
Q1 2018 May 14, 2018	SELL	$12.26 - $18.98 $15,325 - $23,725	-1,250 Reduced 8.47%	13,501 $213,000
Q4 2017 Feb 12, 2018	BUY	$13.68 - $23.17 $201,793 - $341,780	14,751	14,751 $273,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.